Combination Immunotherapy Approaches for Pancreatic Cancer Treatment
Pancreatic ductal adenocarcinoma is a lethal malignant disease with a very low medium survival. Currently, metastatic pancreatic cancer poorly responds to conventional treatments and exhibits an acute resistance to most chemotherapy. Few approaches have been shown to be effective for metastatic panc...
Saved in:
| Main Authors: | Xianliang Cheng, Gang Zhao, Yunqi Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Canadian Journal of Gastroenterology and Hepatology |
| Online Access: | http://dx.doi.org/10.1155/2018/6240467 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Silk Fibroin Nanoparticles for Enhanced Cuproptosis and Immunotherapy in Pancreatic Cancer Treatment
by: Si Gao, et al.
Published: (2025-05-01) -
Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer
by: Ying Ma, et al.
Published: (2024-11-01) -
A thermosensitive hydrogel with synergistic stromal targeting and antitumor immunity modulation for pancreatic cancer immunotherapy
by: Guozhi Zhao, et al.
Published: (2025-06-01) -
Targeting spermine metabolism to overcome immunotherapy resistance in pancreatic cancer
by: Hanshen Yang, et al.
Published: (2025-08-01) -
FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
by: Stefan N. Symeonides, et al.
Published: (2017-08-01)